Dysvascular Amputation Self-Management of Health
Launched by UNIVERSITY OF COLORADO, DENVER · Sep 5, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a specific walking program can help people who have had lower limb amputations due to diabetes or blood circulation issues to be more active. The study aims to see if this program can improve physical activity levels in participants who are aged between 50 and 85 years and have had their leg amputated within the last year. To qualify for the trial, participants must have a confirmed diagnosis of Type II diabetes or a condition called Peripheral Artery Disease, and they should be able to aim for walking around their home with the help of a prosthetic leg.
Participants in the study can expect to engage in a walking intervention program designed to help them increase their physical activity safely. The trial is currently recruiting individuals and is open to all genders. However, certain people may not qualify, such as those who have had amputations due to trauma or cancer, individuals with serious cognitive challenges, or those undergoing active cancer treatment. This study is important because it could lead to better ways for amputees to manage their health and improve their quality of life through increased mobility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Within the age range of 50-85 years
- • Confirmed diagnosis of Type II Diabetes Mellitus (DM) and/or Peripheral Artery Disease (PAD)
- • Transtibial, knee disarticulation, or transfemoral lower-limb amputation (LLA) (or re-amputation) within the past 12 months
- • Participant goal of household walking or better using a prosthesis
- Exclusion Criteria:
- • Trauma or cancer-related etiology of the LLA
- • Decisionally challenged individuals (MMSE score below 24)
- • Prisoners
- • Active cancer treatment
- • Recent stroke (within 2 years)
- • Clinical discretion of principal investigator to exclude patients who are determined to be unsafe and/or inappropriate to participate in the described intervention.
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Cory Christiansen, PT, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials